An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors.
Zhejiang University
Zhejiang University
Azienda Ospedaliero-Universitaria di Parma
University of Nebraska
University of Pennsylvania
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Centre Hospitalier Universitaire Vaudois
Augusta University
Oslo University Hospital
University of Magdeburg
Kantonsspital Winterthur KSW
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
Chinese PLA General Hospital
University of Chicago
Memorial Sloan Kettering Cancer Center